Beta Bionics (BBNX) CEO Saint Sean Sells 5,641 Shares

What Happened Saint Sean, President, CEO and a director of Beta Bionics, sold 5,641 shares on 2026-09-03 in an open-market/private sale (transaction code S). The reported proceeds are $113,259 (weighted average sale price $20.0778; reported price per share $20.08). This transaction was a sale (routine insider liquidation) executed under a pre-established trading plan.

Key Details

• Transaction date: 2026-09-03 (reported on Form 4 filed 2026-09-04).
• Quantity and pricing: 5,641 shares; weighted average sale price $20.0778; reported per-share price $20.08; price range $20.00–$20.1696.
• Total proceeds: approximately $113,259.
• Plan/footnote: Shares sold pursuant to a Rule 10b5-1 plan adopted on September 5, 2025 (footnote F1). Footnote F2 notes the weighted average and price range and that full per-price breakdown can be provided on request.
• Shares owned after transaction: not specified in the information provided.
• Timeliness: Filing appears timely (transaction date 9/3/2026; Form 4 filed 9/4/2026); not marked late.

Context This was a sale under a pre-established 10b5-1 plan, which typically schedules trades in advance and is commonly used to avoid questions about trading on material nonpublic information. Sales do not necessarily indicate management views on the company’s prospects; purchases are often considered more informative about insider sentiment.